Mankind Pharma Partners with Denovo Sciences to Accelerate AI-Driven Drug Discovery
The collaboration between Mankind Pharma and Denovo Sciences launches AI-powered drug discovery to accelerate research timelines and improve lead candidate quality.
Drug Discovery | 02/07/2026 | By News Bureau
Simcere Pharmaceutical and Stanford Medicine Partner on IPF Therapy Research
Simcere Pharmaceutical has entered a research collaboration with Stanford Medicine to develop innovative therapies for Idiopathic Pulmonary Fibrosis (IPF).
Drug Discovery | 16/06/2026 | By News Bureau
GVRP and Steps Biosciences Launch Advanced Formulations Research Centre in Bengaluru
GVRP and Steps Biosciences have inaugurated the GVRP StepsBio Research Centre (GSRC) at Bengaluru’s Lifescapes life sciences cluster, strengthening India’s pharmaceutical innovation ecosystem with advanced facilities for complex formulations, sterile injectables, analytical testing and AI-enabled drug development.
Drug Discovery | 06/06/2026 | By News Bureau
Fauna Bio Announces Target Designation Milestone in Obesity Discovery Collaboration
Fauna Bio has achieved a target designation milestone in its obesity discovery collaboration, advancing a novel target identified through its Convergence AI platform.
Drug Discovery | 20/03/2026 | By News Bureau | 119
Dalriada Drug Discovery and Topos Bio collaborate to accelerate drug discovery for intrinsically disordered proteins using AI, mass spectrometry and proteomics to improve experimental validation and therapeutic development.
Drug Discovery | 18/03/2026 | By News Bureau | 162
Roche Boosts AI Muscle with Nvidia Chip Expansion to Accelerate Drug Discovery
Swiss pharma major Roche has significantly expanded its artificial intelligence (AI) capabilities by deploying thousands of advanced GPUs from Nvidia, marking one of the largest AI infrastructure investments in the pharmaceutical sector.
Drug Discovery | 17/03/2026 | By Darshana | 140
Syngene Partners with Johns Hopkins University for Early Drug Discovery
The collaboration between Syngene International and John Hopkins University is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research.
Drug Discovery | 13/02/2026 | By News Bureau | 170
Illumina has completed its USD 350 million acquisition of SomaLogic, strengthening its multiomics portfolio and expanding large-scale proteomics capabilities to accelerate drug discovery and improve patient outcomes.
Drug Discovery | 02/02/2026 | By News Bureau | 937
FAR Biotech Sets Up Operations in Wisconsin, Expands QuantumAI Programmes
Far Biotech, part of the Johnson & Johnson Innovation JLABS ecosystem, is advancing a quantum mechanics-based, AI-powered approach to drug discovery as it expands operations in Madison, Wisconsin.
Drug Discovery | 22/01/2026 | By News Bureau | 237
Adaptive Biotechnologies Signs Two Immune Receptor Licensing Deals with Pfizer
Adaptive Biotechnologies has signed two immune receptor licensing agreements with Pfizer, covering a T-Cell Receptor (TCR) discovery collaboration in rheumatoid arthritis and access to Adaptive’s proprietary TCR-antigen datasets for immunology R&D.
Drug Discovery | 16/12/2025 | By News Bureau | 237
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy